Autophagy is a lysosome-dependant intracellular degradation process that eliminates long-lived proteins as well as damaged organelles from the cytoplasm. An increasing body of evidence suggests that dysregulation of this system plays a pivotal role in the etiology and/or progression of neurodegenerative diseases including motor neuron disorders. Herein, we review the latest findings that highlight the involvement of autophagy in the pathogenesis of amyotrophic lateral sclerosis (ALS) and the potential role of this pathway as a target of therapeutic purposes. Autophagy promotes the removal of toxic, cytoplasmic aggregate-prone pathogenetic proteins, enhances cell survival, and modulates inflammation. The existence of several drugs targeting this pathway can facilitate the translation of basic research to clinical trials for ALS and other motor neuron diseases.

Autophagy in motor neuron disease: Key pathogenetic mechanisms and therapeutic targets / M.S. Cipolat Mis, S. Brajkovic, E. Frattini, A. Di Fonzo, S. Corti. - In: MOLECULAR AND CELLULAR NEUROSCIENCES. - ISSN 1044-7431. - 72(2016), pp. 84-90.

Autophagy in motor neuron disease: Key pathogenetic mechanisms and therapeutic targets

S. Brajkovic
Secondo
;
E. Frattini;A. Di Fonzo
Penultimo
;
S. Corti
2016

Abstract

Autophagy is a lysosome-dependant intracellular degradation process that eliminates long-lived proteins as well as damaged organelles from the cytoplasm. An increasing body of evidence suggests that dysregulation of this system plays a pivotal role in the etiology and/or progression of neurodegenerative diseases including motor neuron disorders. Herein, we review the latest findings that highlight the involvement of autophagy in the pathogenesis of amyotrophic lateral sclerosis (ALS) and the potential role of this pathway as a target of therapeutic purposes. Autophagy promotes the removal of toxic, cytoplasmic aggregate-prone pathogenetic proteins, enhances cell survival, and modulates inflammation. The existence of several drugs targeting this pathway can facilitate the translation of basic research to clinical trials for ALS and other motor neuron diseases.
Authophagy; Amyotrophic lateral sclerosis; Protein aggregation
Settore MED/26 - Neurologia
2016
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1044743116300124-main for my air.pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 579.38 kB
Formato Adobe PDF
579.38 kB Adobe PDF Visualizza/Apri
1-s2.0-S1044743116300124-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 493.56 kB
Formato Adobe PDF
493.56 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/398217
Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 38
social impact